tiprankstipranks
Trending News
More News >
RemeGen Co. Ltd. Class H (HK:9995)
:9995

RemeGen Co. Ltd. Class H (9995) Similar Stocks

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RemeGen Co. Ltd. Class H
HK$77.50
HK$47.26B
-41.06
398.07%
4 Buy
3 Hold
0 Sell
Moderate Buy
Genscript Biotech
HK$12.85
HK$27.90B
-19.65
29.41%
3 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$22.18
HK$15.11B
-8.87
-36.76%
5 Buy
2 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$22.98
HK$36.27B
-22.40
81.23%
0 Buy
1 Hold
1 Sell
Moderate Sell
Simcere Pharmaceutical Group Limited
HK$12.85
HK$33.35B
33.29
85.02%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$59.85
HK$32.53B
37.04
172.58%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9995
RemeGen Co. Ltd. Class H
77.50
61.94
398.07%
HK:1548
Genscript Biotech
12.85
2.92
29.41%
HK:9688
Zai Lab Ltd
13.47
-7.83
-36.76%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
22.98
10.38
82.38%
HK:2096
Simcere Pharmaceutical Group Limited
12.60
5.84
86.39%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
60.65
36.80
154.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts